EIF2AK3 and neoplasm: In melanoma models, the PERK inhibitor GSK2656157 combined with an mRNA vaccine promotes M1 macrophage polarization and enhances CD8(+) T cell infiltration, significantly suppressing tumor growth and metastasis [97].